Illumina Accelerator is accepting applications for its next funding cycle in the San Francisco Bay Area. Illumina Accelerator is the world’s first business accelerator focused on creating an innovation ecosystem for the genomics industry. It drives value for genomics startups developing breakthrough applications in therapeutics, diagnostics, agriculture, direct to consumer, synthetic biology, and beyond. Selected genomics startups will receive access to capital, business guidance, and fully operational lab space for six months in the San Francisco Bay Area, starting in Spring 2019. Applications for the ninth funding cycle are due by November 1, 2018.
About the Illumina Accelerator
Illumina Accelerator is the world’s first business accelerator focused solely on creating an innovation ecosystem for the genomics industry. During the six-month funding cycle, each startup will gain access to seed investment, access to Illumina sequencing systems and reagents, a subscription to our BaseSpace Correlation Engine and BaseSpace Cohort Analyzer translational genomics databases, as well as business guidance and fully operational lab space in the San Francisco Bay Area. View FAQs HERE.